Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
SMS Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:532815NSE Symbol: SMSPHARMAP/E(TTM):37.04
ISIN Demat:INE812G01025Div & Yield %:0.12EPS(TTM):8.66
Book Value(Rs):81.1841562Market Cap ( Cr.):3003.89Face Value(Rs):1
    Change Company 
Date Headline
04-Dec-25 SMS Pharmaceuticals receives revision in credit ratings from CARE
26-Nov-25 SMS Pharmaceuticals' associate company receives USFDA approval for Ranitidine tablets
26-Nov-25 SMS Pharma spurts after associate firm secures USFDA nod for reformulated Ranitidine tablets
26-Nov-25 Indo US Bio-Tech Ltd leads gainers in 'B' group
10-Nov-25 Barometers trade with strong gains; consumer durable shares rally
10-Nov-25 SMS Pharma spurts after Q2 PAT climbs 79% YoY to Rs25 cr
08-Nov-25 SMS Pharmaceuticals consolidated net profit rises 79.50% in the September 2025 quarter
07-Nov-25 SMS Pharmaceuticals Ltd - SMS Pharmaceuticals Limited - Updates
03-Nov-25 SMS Pharmaceuticals declare Quarterly Result
16-Oct-25 SMS Pharmaceuticals Ltd - Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requireme..
<< < 1 2 3 4   > >>